1. Home
  2. Search

Search

Search results

545 results found

Bertan Cakir, MD

Person: Ophthalmology Resident, Class of 2024
Dr. Bertan Cakir was born and raised in Gelsenkirchen, Germany located in the western part of the country. He earned his medical degree from the University of Lübeck, Germany and started his ophthalmology residency training at the University of Freiburg. In his second year of residency he was...

Treatment and Outcomes for IRDs

Page
Until the approval of Luxturna®, there were no definitive treatments for any IRDs. Today, with the success of Luxturna®, preliminary results from therapies currently under investigation, and an expanding therapeutic toolkit, we have good reason for optimism. We envision a future in which gene...

Applications and Referrals

Page
Applications to Other Diseases The same types of genetic strategies currently being tested for IRDs are also being tested and beginning to receive regulatory approvals in other areas of medicine. For example, the FDA has approved both gene-augmentation therapy and antisense oligonucleotide therapy...

eye Insights 13: Posterior Uveitis

Page
In this issue of eye Insights, we explore posterior uveitis and its varied etiologies. Inside, you’ll find common causes, tips for diagnosing posterior uveitis, and treatment techniques. Inside Message from Editor-in-Chief What is Posterior Uveitis Diagnosis Treatment Checkpoint Inhibitors Editor-in...

Treatment

Page
Treatment of Infectious Uveitis Treatment of infectious uveitis is dependent on the specific microbe. Treatment of Non-infectious Uveitis Anti-inflammatories Periocular, intravitreal, or systemic steroids are the mainstay of the acute treatment of non-infectious posterior uveitis. Topical steroids...

Ula Jurkunas, MD, Inducted into the American Ophthalmological Society

News: April 07, 2022
Ula Jurkunas, MD, Associate Professor of Ophthalmology at Harvard Medical School, has been elected to the prestigious American Ophthalmological Society for her distinguished contributions to the field, particularly her research in Fuchs' endothelial corneal dystrophy and corneal stem cell...

Faculty Shine at 2022 World Medical Innovation Forum

News: May 13, 2022
Several Harvard Ophthalmology faculty shared cutting-edge insights on gene and cell therapy at the 2022 World Medical Innovation Forum. Presented by Mass General Brigham, the forum featured speakers from industry, academia, and government who are shaping the future of gene and cell therapies. Five...